UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

March 26, 2024

https://www.prnewswire.com/news-releases/update-nrx-pharmaceuticals-nasdaq-nrxp-to-report-fourth-quarter-and-full-year-2023-financial-results-on-march-28-2024-302100135.html

RADNOR, Pa., March 26, 2024 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it will release its fourth quarter and full year 2023 financial results after the market closes on Thursday, March 28, 2024, via press release, which will be available on the Company’s website at https://ir.nrxpharma.com/press-releases. Due to scheduling conflicts and the Good Friday stock market holiday, the Company will now host its conference call to discuss the financial results as well as provide a corporate update on Monday, April 1, 2024, at 8:30 a.m. ET.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.